Ana Marcos-Jimenez

4PUBLICATIONS
19CO-AUTHORS
Molecular targetsInnate immunityHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Aug 05, 2026
Dasatinib reversibly disrupts T cell motility and activation in lymph nodes.

|Mar 07, 2024
NFκB and NLRP3/NLRC4 inflammasomes regulate differentiation, activation and functional properties of monocytes in response to distinct SARS-CoV-2 proteins.

Ilya Tsukalov, Ildefonso Sánchez-Cerrillo, Olga Rajas

|Dec 30, 2022
Dasatinib-induced spleen contraction leads to transient lymphocytosis.

Ana Marcos-Jiménez, Daniela Claudino Carvoeiro, Nora Ruef

|Jun 10, 2022
Ibrutinib Does Not Impact CCR7-Mediated Homeostatic Migration in T-Cells from Chronic Lymphocytic Leukemia Patients.

Tamara Mateu-Albero, Ana Marcos-Jimenez, Stefanie Wissmann

Pageof 1

Frequent Collaborators

3 joint publications

Jens V Stein

2 joint publications

Daniela Claudino Carvoeiro

2 joint publications

Cecilia Muñoz-Calleja

2 joint publications

Enrique Martin-Gayo